Current Studies

We are currently seeking individuals to participate in our clinical studies.  Study participants will receive study medication, study-related procedures at no cost and may also receive compensation for time and travel.

Please check back regularly for potential studies which may be of interest to you. You can also give us at call at 316-425-6333 to inquire about our studies or register online.

List of Current Studies


Juveena – Intrauterine gel implant for prevention of adhesions or scar tissue formation (Click here to learn more)

The purpose of this study is to learn if filling the uterus with a soft gel-like material (Juveena Hydrogel) at the end of your gynecological surgical procedure can safely and effectively reduce the development of intrauterine adhesions (fibrous scar tissue).

E.mbrace – Vaccine for prevention of blood infection caused by E.coli (Click here to learn more)

The purpose of this clinical research study is to assess the efficacy and safety of an investigational vaccine in the prevention of a blood infection caused by E. coli bacteria.

INTIBIA – Urge Urinary Incontinence Study (Click here for more information)

The Intibia is a single-use, programmable implantable tibial nerve stimulator. The purpose of this study is to demonstrate the safety and effectiveness of the INTIBIA system for the treatment of urge urinary incontinence.

SPRUCE – Polycystic Ovary Syndrome Study (PCOS) (Click here for more information)

This study is evaluating the safety and effectiveness of Tildacerfont, compared to placebo, after 12 weeks of treatment in patients with polycystic ovary syndrome or PCOS.

NEXPLANON – Contraceptive Implant Study (Click here to learn more)

The Nexplanon® implant is approved for use to prevent pregnancies for up to 3 years. It has not been approved to use for more than 3 years. The purpose of this clinical trial is to confirm that the use of the implant for more than 3 years: remains effective to prevent pregnancy, remains safe, maintains menstrual cycle (periods) control.

EAGLE-2 Urinary Tract Infection Study (Click here to learn more)

Researchers are investigating the safety and effectiveness of an investigational medication in the treatment of UTI's in females over 18 years of age.

DARE – Female Sexual Arousal Disorder (Click here to learn more)

Female Sexual Arousal Disorder study is evaluating an investigational cream (home use) for premenopausal women who experience difficulty in maintaining a sufficient physical response to sexual stimulation.

ELARIS EM-COC Endometriosis Study (Click here to learn more)

The ELARIS EM-COC study is evaluating the safety and effectiveness of an oral investigational medication when taken together with a combined oral contraceptive that contains estrogen and progesterone, in premenopausal women that are experiencing endometriosis pain.